免疫组织化学市场报告：2031 年趋势、预测与竞争分析

全球免疫组织化学市场在医院和诊断实验室、学术和研究机构市场前景光明。预计到 2031 年，全球免疫组织化学市场规模将达到 42 亿美元，2025 年至 2031 年的复合年增长率为 5.4%。该市场的主要驱动力是医疗保健专业人员越来越多地采用数位病理学、慢性病患病率上升以及已开发国家老年人口的快速增长。

• Lucintel 表示，从应用角度来看，由于慢性病盛行率不断上升，诊断应用预计将在预测期内实现最高成长。
• 根据最终用途行业，医院和诊断实验室预计将仍然是最大的细分市场，因为医院越来越多地将诊断程序转移到内部。
• 由于各国政府大力投资医疗保健基础设施和服务，预计亚太地区将在预测期内达到最高成长。

免疫组织化学市场的策略性成长机会

由于技术进步和各种应用需求的不断增长，免疫组织化学市场呈现多种策略成长机会。这些机会正在塑造 IHC 解决方案的未来。

• 扩大肿瘤学应用：IHC 在癌症诊断和监测中的应用具有巨大的成长潜力。增强的生物标记检测和新颖的检测方法可支援更准确的癌症诊断和个人化治疗。
• 自动化解决方案的开发：市场为自动化 IHC 染色系统的开发提供了成长机会。自动化是提高实验室效率和一致性的关键投资和发展领域。
• 与数位病理学结合：将 IHC 与数位病理学解决方案相结合可增强资料分析和解释，创造​​成长机会。这种整合支援更有效率、更准确的诊断和研究。
• 专注于新兴市场：透过提供价格合理、适合当地情况的 IHC 解决方案，向新兴市场扩张可带来成长机会。扩展到新兴市场可以满足当地需求并扩大市场范围。
• 个人化医疗的进步：IHC 在个人化医疗中的应用正在不断扩大，为开发针对个别患者特征的检测方法提供了机会。这一趋势支持更有针对性和更有效的治疗。

这些成长机会凸显了免疫组织化学市场在肿瘤学、自动化、数位病理学、新兴市场和个人化医疗方面的扩张潜力。在这些领域投资将推动创新和市场成长。

免疫组织化学市场驱动因素与挑战

免疫组织化学市场受到各种市场驱动因素和挑战的影响，包括技术进步、经济因素和监管问题。了解这些因素对于有效驾驭市场至关重要。

推动免疫组织化学市场发展的因素有：

• 技术进步：多重分析和高解析度成像等 IHC 技术的创新正在推动市场成长。这些进步提高了诊断能力并扩大了应用领域。
• 癌症发病率上升：全球癌症发病率上升推动了对用于准确诊断和研究的先进 IHC 解决方案的需求。这些不断增长的需求正在支持市场扩张。
• 研发成长：不断增加的研发投入正在推动 IHC 产品和技术的创新。这项投资支持了新检测方法和解决方案的开发。
• 实验室自动化：采用自动化 IHC 染色系统提高了实验室的效率和一致性。自动化支援高吞吐量环境并提高生产力。
• 与数位病理学的整合：IHC 与数位病理学解决方案的整合正在推动资料分析和解释，提高诊断准确性和研究能力。

免疫组织化学市场面临的挑战是：

• 开发成本高：开发先进的 IHC 技术需要大量的研发成本。对于小型企业和新兴企业来说，这些高成本可能是一个障碍。
• 法规遵循：满足 IHC 产品的法规要求可能具有挑战性，尤其是在某些地区。确保遵守标准对于市场进入和业务运营至关重要。
• 整合复杂性：将新的 IHC 技术整合到现有系统中可能很复杂。确保相容性和无缝操作需要专业知识和周密的规划。
• 市场竞争：IHC 市场竞争激烈，许多公司提供类似的产品。为了获得竞争优势，您需要透过创新和性能来实现差异化。
• 经济不确定性：经济波动和不确定性可能会影响 IHC 领域的研究和开发资金。这些经济因素可能会影响市场成长和投资。

免疫组织化学市场正受到技术进步、癌症盛行率上升和自动化等驱动因素的影响，同时面临高昂的开发成本和法规遵循等挑战。解决这些市场驱动因素和挑战对于市场的成功和成长至关重要。

目录

第一章执行摘要

第 2 章全球免疫组织化学市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动力与挑战

第三章市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）及预测（2025-2031）
• 全球免疫组织化学市场趋势（2019-2024）及预测（2025-2031）
• 全球免疫组织化学市场（按产品）
  • 抗体
  • 试剂
  • 装置
  • 套件
• 全球免疫组织化学市场（按应用）
  • 诊断用途
  • 研究用途
  • 法医学应用
• 全球免疫组织化学市场（按最终用途行业划分）
  • 医院和诊断实验室
  • 学术和研究机构
  • 其他最终用户

第四章区域市场趋势与预测分析（2019-2031）

• 全球免疫组织化学市场（按地区）
• 北美免疫组织化学市场
• 欧洲免疫组织化学市场
• 亚太免疫组织化学市场
• 世界其他地区的免疫组织化学市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球免疫组织化学市场成长机会（按类型）
  • 全球免疫组织化学市场的成长机会（按应用）
  • 全球免疫组织化学市场成长机会（依最终用途产业划分）
  • 全球免疫组织化学市场各区域成长机会
• 全球免疫组织化学市场的新趋势
• 战略分析
  • 新产品开发
  • 全球免疫组织化学市场产能扩张
  • 全球免疫组织化学市场的企业合併
  • 认证和许可

第七章主要企业简介

• F.Hoffmann-LA-Roche
• Danaher
• Agilent Technologies
• Merck KGAA
• Bio-Rad Laboratories
• Eagle Biosciences
• Biocare Medical
• Elabscience Biotechnology
• Bio-Genex Laboratories
• Diagnostic Biosystem
• Histo-Line Laboratories

The future of the global immunohistochemistry market looks promising with opportunities in the hospitals & diagnostic laboratory, and academic & research institute markets. The global immunohistochemistry market is expected to reach an estimated $4.2 billion by 2031 with a CAGR of 5.4% from 2025 to 2031. The major drivers for this market are the increasing adoption of digital pathology by healthcare professionals, the rising prevalence of chronic diseases, and the surge in the geriatric population in developed countries.

• Lucintel forecasts that, within the application category, diagnostic application is expected to witness the highest growth over the forecast period due to the rising incidence of chronic illnesses.
• Within the end use industry category, hospitals & diagnostic laboratories will remain the largest segment due to increasing trend of hospitals conducting diagnostic procedures in-house.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to government is making substantial investments in healthcare infrastructure and services.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Immunohistochemistry Market

The immunohistochemistry market is experiencing key trends driven by technological advancements and increasing demand for precise diagnostics. These trends are shaping the future of IHC applications and solutions.

• Multiplex IHC Assays: Multiplex assays enable the simultaneous detection of multiple biomarkers in a single sample. This trend enhances diagnostic accuracy and research capabilities by providing comprehensive data in one analysis.
• Automated Staining Systems: The adoption of automated IHC staining systems is increasing efficiency and consistency in laboratories. These systems reduce manual errors and improve reproducibility, making them crucial for high-throughput environments.
• AI and Machine Learning Integration: AI and machine learning are being integrated into IHC image analysis, enhancing the accuracy of biomarker detection and interpretation. These technologies enable more precise and faster data analysis.
• Enhanced Imaging Techniques: High-resolution imaging techniques are advancing, providing more detailed and accurate visualization of tissue samples. These techniques support better diagnostics and research outcomes by improving biomarker detection.
• Localized Solutions and Cost Reduction: There is a focus on developing localized IHC solutions to address regional needs and reduce costs. This trend aims to make IHC more accessible and affordable in emerging markets.

These trends are reshaping the immunohistochemistry market by improving diagnostic precision, efficiency, and accessibility. The focus on multiplex assays, automation, AI integration, enhanced imaging, and localized solutions is driving innovation and expanding the applications of IHC technologies.

Recent Developments in the Immunohistochemistry Market

Recent developments in the immunohistochemistry market highlight advancements in technology, automation, and regional growth. These developments are enhancing the capabilities and applications of IHC in diagnostics and research.

• Introduction of Multiplex IHC Assays: New multiplex IHC assays allow for the detection of multiple biomarkers simultaneously, improving diagnostic accuracy and research efficiency. This development supports a more comprehensive analysis of complex diseases.
• Advancement in Automated Staining Systems: Automation in IHC staining systems is increasing, with new systems offering higher throughput and consistency. These advancements reduce manual errors and streamline laboratory workflows.
• Integration of AI in Image Analysis: AI technologies are being incorporated into IHC image analysis, improving the accuracy of biomarker detection and data interpretation. This integration enhances research and diagnostic precision.
• Development of High-Resolution Imaging Techniques: High-resolution imaging techniques are advancing, providing more detailed visualization of tissue samples. This development supports better biomarker detection and enhances diagnostic capabilities.
• Expansion of Localized IHC Solutions: There is a growing focus on developing localized IHC solutions to meet regional needs and reduce costs. This expansion is making IHC more accessible in emerging markets.

These developments are advancing the immunohistochemistry market by enhancing diagnostic capabilities, improving efficiency, and expanding accessibility. Innovations in multiplex assays, automation, AI integration, high-resolution imaging, and localized solutions are driving progress in this field.

Strategic Growth Opportunities for Immunohistochemistry Market

The immunohistochemistry market presents several strategic growth opportunities driven by technological advancements and increasing demand across various applications. These opportunities are shaping the future of IHC solutions.

• Expansion in Oncology Applications: There is significant growth potential in using IHC for cancer diagnostics and research. Enhanced biomarker detection and new assays are supporting more accurate cancer diagnoses and personalized treatments.
• Development of Automated Solutions: The market offers growth opportunities in developing automated IHC staining systems. Automation improves laboratory efficiency and consistency, making it a key area for investment and development.
• Integration with Digital Pathology: Integrating IHC with digital pathology solutions creates growth opportunities by enhancing data analysis and interpretation. This integration supports more efficient and accurate diagnostics and research.
• Focus on Emerging Markets: Expanding into emerging markets presents growth opportunities by providing affordable and localized IHC solutions. This expansion addresses regional needs and increases market reach.
• Advancements in Personalized Medicine: The application of IHC in personalized medicine is growing, with opportunities to develop assays tailored to individual patient profiles. This trend supports more targeted and effective treatments.

These growth opportunities highlight the potential for expanding the immunohistochemistry market across oncology, automation, digital pathology, emerging markets, and personalized medicine. Capitalizing on these areas will drive innovation and market growth.

Immunohistochemistry Market Driver and Challenges

The immunohistochemistry market is influenced by various drivers and challenges, including technological advancements, economic factors, and regulatory issues. Understanding these factors is essential for navigating the market effectively.

The factors responsible for driving the immunohistochemistry market include:

• Technological Advancements: Innovations in IHC technology, such as multiplex assays and high-resolution imaging, are driving market growth. These advancements improve diagnostic capabilities and expand application areas.
• Increasing Cancer Incidence: The rising incidence of cancer globally is driving demand for advanced IHC solutions for accurate diagnostics and research. This growing need supports market expansion.
• Growth in Research and Development: Increased investment in research and development is fostering innovation in IHC products and technologies. This investment drives the development of new assays and solutions.
• Automation in Laboratories: The adoption of automated IHC staining systems is improving efficiency and consistency in laboratories. Automation supports high-throughput environments and enhances productivity.
• Integration with Digital Pathology: Integrating IHC with digital pathology solutions is advancing data analysis and interpretation, enhancing diagnostic accuracy and research capabilities.

Challenges in the immunohistochemistry market are:

• High Development Costs: Developing advanced IHC technologies involves significant research and development costs. These high costs can be a barrier for smaller companies and startups.
• Regulatory Compliance: Meeting regulatory requirements for IHC products, particularly in different regions, can be challenging. Ensuring compliance with standards is essential for market entry and operation.
• Complexity of Integration: Integrating new IHC technologies with existing systems can be complex. Ensuring compatibility and seamless operation requires expertise and careful planning.
• Market Competition: The IHC market is competitive, with numerous players offering similar products. Companies must differentiate themselves through innovation and performance to gain a competitive edge.
• Economic Uncertainties: Economic fluctuations and uncertainties can impact funding for research and development in the IHC sector. These economic factors can affect market growth and investment.

The immunohistochemistry market is shaped by drivers such as technological advancements, increasing cancer incidence, and automation, while facing challenges like high development costs and regulatory compliance. Addressing these drivers and challenges is crucial for success and growth in the market.

List of Immunohistochemistry Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, immunohistochemistry companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the immunohistochemistry companies profiled in this report include-

• F.Hoffmann-LA-Roche
• Danaher
• Agilent Technologies
• Merck KGAA
• Bio-Rad Laboratories
• Eagle Biosciences
• Biocare Medical
• Elabscience Biotechnology
• Bio-Genex Laboratories
• Diagnostic Biosystem

Immunohistochemistry by Segment

The study includes a forecast for the global immunohistochemistry market by product, application, end use industry, and region.

Immunohistochemistry Market by Product [Analysis by Value from 2019 to 2031]:

• Antibodies
• Reagents
• Equipment
• Kits

Immunohistochemistry Market by Application [Analysis by Value from 2019 to 2031]:

• Diagnostic Applications
• Research Applications
• Forensic Applications

Immunohistochemistry Market by End Use Industry [Analysis by Value from 2019 to 2031]:

• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Other End Users

Immunohistochemistry Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Immunohistochemistry Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. Below are recent developments by major immunohistochemistry producers in key regions: the USA, China, India, Japan, and Germany.

• United States: In the U.S., significant advancements include the introduction of multiplex IHC assays that allow for simultaneous detection of multiple biomarkers. This development enhances diagnostic accuracy and research capabilities, particularly in oncology and neurology.
• China: China is focusing on improving the quality and cost-efficiency of IHC products. The country is seeing growth in domestic production of IHC reagents and antibodies, leading to increased availability and affordability of these tools for research and clinical applications.
• Germany: Germany is leading innovations in automated IHC staining systems, which enhance throughput and consistency in laboratories. These systems are becoming more sophisticated, incorporating artificial intelligence for better image analysis and data interpretation.
• India: India is witnessing increased adoption of IHC in diagnostic laboratories due to a rise in cancer cases. There is also a push towards developing localized IHC solutions to meet specific regional needs and improve healthcare accessibility.
• Japan: Japan is advancing in the development of high-resolution IHC imaging techniques. These techniques improve the detection and quantification of biomarkers, supporting more precise diagnostics and research in various disease areas.

Features of the Global Immunohistochemistry Market

Market Size Estimates: Immunohistochemistry market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Immunohistochemistry market size by various segments, such as by product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Immunohistochemistry market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the immunohistochemistry market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the immunohistochemistry market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the immunohistochemistry market by product (antibodies, reagents, equipment, and kits), application (diagnostic applications, research applications, and forensic applications), end use industry (hospitals & diagnostic laboratories, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Immunohistochemistry Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Immunohistochemistry Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Immunohistochemistry Market by Product
  • 3.3.1: Antibodies
  • 3.3.2: Reagents
  • 3.3.3: Equipment
  • 3.3.4: Kits
• 3.4: Global Immunohistochemistry Market by Application
  • 3.4.1: Diagnostic Applications
  • 3.4.2: Research Applications
  • 3.4.3: Forensic Applications
• 3.5: Global Immunohistochemistry Market by End Use Industry
  • 3.5.1: Hospitals & Diagnostic Laboratories
  • 3.5.2: Academic & Research Institutes
  • 3.5.3: Other end users

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Immunohistochemistry Market by Region
• 4.2: North American Immunohistochemistry Market
  • 4.2.1: North American Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.2.2: North American Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users
• 4.3: European Immunohistochemistry Market
  • 4.3.1: European Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.3.2: European Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users
• 4.4: APAC Immunohistochemistry Market
  • 4.4.1: APAC Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.4.2: APAC Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users
• 4.5: ROW Immunohistochemistry Market
  • 4.5.1: ROW Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.5.2: ROW Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Immunohistochemistry Market by Product
  • 6.1.2: Growth Opportunities for the Global Immunohistochemistry Market by Application
  • 6.1.3: Growth Opportunities for the Global Immunohistochemistry Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Immunohistochemistry Market by Region
• 6.2: Emerging Trends in the Global Immunohistochemistry Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Immunohistochemistry Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunohistochemistry Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F.Hoffmann-LA-Roche
• 7.2: Danaher
• 7.3: Agilent Technologies
• 7.4: Merck KGAA
• 7.5: Bio-Rad Laboratories
• 7.6: Eagle Biosciences
• 7.7: Biocare Medical
• 7.8: Elabscience Biotechnology
• 7.9: Bio-Genex Laboratories
• 7.10: Diagnostic Biosystem
• 7.11: Histo-Line Laboratories